Search results
I just put £4k into my SIPP. Here’s where I’m going to invest it
Motley Fool UK· 6 days agoInvesting in a SIPP (Self-Invested Personal Pension) is one of the best ways to build wealth for...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 6 days ago, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab,...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
Daily Telegraph· 3 days agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 4 days agoG1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial.
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 2 days agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance UK· 7 days agoJ&J faces the upcoming patent expiration of Stelara in 2025 and talc litigations. AbbVie, Merck,...
LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake
Morningstar· 3 days ago"One question that everyone asks is whether last week's good news marked the finale of the Nvidia's surge to the top, and if the past three-day selloff is the beginning of a sharper downside ...
The UK stock market is brimming with hidden value. Here are some top picks to consider in July
Fool.co.uk via Yahoo Finance UK· 6 days agoI'm looking for the most promising shares on the UK stock market this month. Here are three that I...
The UK stock market is brimming with hidden value. Here are some top picks to consider in July
Motley Fool UK· 6 days agoThe UK stock market is doing well this year but things have slowed down as the summer holidays...
FTSE 100 movers: Admiral boosted by upgrade; Melrose, Rolls-Royce slump
ShareCast· 2 days agoLondon’s FTSE 100 was down 0.3% at 8,258.89 in afternoon trade on Tuesday.